Home
Qiming U.S. Healthcare Fund III reported a 8.3% stake in Satellos Bioscience MSLE · 1,725,247 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 8.3%
- Last report
- First report
- Shares held
- 1,725,247 sh
- Class
- Common Shares, no par value
- Event date
- 26/03/31
- Filed
- 26/05/12
First 5%+ report · 8.3% stake
Satellos Bioscience trades, last 26 weeks
What else happened in Satellos Bioscience around then
Filed or reported within 30 days of the trade day · 03/01~04/30Qiming U.S. Healthcare Fund III's other 5% stake reports
No other trades yet.